Discovery, Development, Inventions, and Patent Trends on Mobocertinib Succinate: The First-in-Class Oral Treatment for NSCLC with EGFR Exon 20 Insertions von Imran, Mohd, Khan, Shah Alam, Alshammari, Mohammed Kanan, Alreshidi, Meshal Ayedh, Alreshidi, Abeer Abdullah, Alghonaim, Rawan Sulaiman, Alanazi, Fayez Aboud, Alshehri, Sultan, Ghoneim, Mohammed M., Shakeel, Faiyaz

Volltext